Effects of antiretroviral drugs on the translocation status of Human Immunodeficiency Virus type 1 reverse transcriptase
The reverse transcriptase of the Human Immunodeficiency Virus type 1 (HIV-1) is responsible for transcribing the viral single-stranded RNA genome into double-stranded DNA. Due to its vital role in the viral life cycle, it is often targeted in the treatment of HIV-1 infected patients. Inhibitors th...
Main Author: | Marchand, Bruno |
---|---|
Other Authors: | Matthias Gotte (Internal/Supervisor) |
Format: | Others |
Language: | en |
Published: |
McGill University
2007
|
Subjects: | |
Online Access: | http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=18278 |
Similar Items
-
HIV-1 reverse transcriptase-associated ribonuclease H activity: novel mechanisms of inhibition
by: Beilhartz, Gregory
Published: (2012) -
HIV-1 reverse transcriptase: Determinants and impact of the translocational equilibrium with implications for drug resistance
by: Scarth, Brian
Published: (2011) -
The Structural Dynamics of Human Immunodeficiency Virus Type I Reverse Transcriptase
by: Seckler, James Malcolm
Published: (2011) -
New drug resistance mutations of reverse transcriptase Human immunodeficiency virus type-1 gene in first-line antiretroviral-infected patients in West Sumatra, Indonesia
by: Efrida Efrida, et al.
Published: (2018-05-01) -
Inhibition of human immunodeficiency virus type 1 by niclosamide through mTORC1 inhibition
by: Nattamon Niyomdecha, et al.
Published: (2020-06-01)